| AgNPs | Silver nanoparticles |
| WHO | World Health Organization; |
| CDC | Communicable Disease Center |
| FDA | Food and Drug Administration |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| E. aerogenes | Enterobacter aerogenes |
| S. typhimurium | Salmonella typhimurium |
| S. aureus | Staphylococcus aureus |
| E. faecalis | Enterococcus faecalis |
| B. cereus | Bacillus cereus |
| E. coli | Escherichia coli |
| S. flexneri | Shigella flexneri |
| MBC | Minimum Bactericidal Concentration |
| TGA | Thermogravimetric analysis |
| MIC50 | Minimum inhibitory concentration 50 |
| THF | Tetrahydrofuran |
| CH3CN | Acetonitrile |
| FTIR | Fourier-transform infrared spectroscopy |
| HCl | Hydrochloric acid |
| UV-Vis | Ultraviolet-visible spectroscopy |
| MeOH | Methanol |
| DMSO | Dimethylsulfoxide |
| AFM | Atomic force microscopy |
| PVP | Polyvinylpyrrolidone |
| MTT | (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium |
| DLS | Dynamic Light Scattering |
| HHF | Human Foreskin Fibroblast |
| KBr | Potassium bromide |
| DCM | Dichloromethane |
| DMF | Dimethylformamide |